101
Participants
Start Date
May 15, 2017
Primary Completion Date
December 15, 2021
Study Completion Date
November 15, 2022
Gemcitabine plus cisplatin
Gemcitabine 1,000 mg/m2 and cisplatin 25 mg/m2 Day 1 and 8, every 3 weeks
Capecitabine
Capecitabine 1,250 mg/m2 Day 1 to 14, every 3 weeks
Asan Medical Center, University of Ulsan College of Medicine, Seoul
Lead Sponsor
Bundang CHA Hospital
OTHER
Seoul St. Mary's Hospital
OTHER
Severance Hospital
OTHER
Asan Medical Center
OTHER